Adults with treated inflammatory bowel disease experience significantly lower grip strength and reduced appendicular lean mass index compared to healthy individuals, with a steeper age-related decline in muscle strength over time. The analysis of 5,522 adults from NHANES data revealed this pattern persisted even after accounting for age, sex, and BMI differences. This finding expands our understanding of IBD's systemic impact beyond the digestive tract. The accelerated muscle loss suggests that chronic inflammation continues to drive catabolic processes despite therapeutic intervention, potentially through cytokine-mediated protein breakdown or altered nutrient absorption. For the estimated 3 million Americans with IBD, this represents a critical but overlooked comorbidity that could substantially impact long-term functional independence and quality of life. The study's small IBD sample size of 25 individuals limits statistical power, though the consistency of findings across multiple muscle parameters strengthens confidence. Most importantly, these results suggest that current IBD treatment protocols may need to incorporate proactive muscle health monitoring and targeted interventions like resistance training and protein optimization to prevent premature functional decline.